Loading...
Loading...
Stemtech Corp
Stemtech Corp. Spoken Alpha tracks STEK's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks STEK's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for STEK.
curl https://api.spokenalpha.com/v1/companies/STEK| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.95 | $2.39 | -18.6% | -8.6% | -6.8% |
| Q4 FY2026 | $2.07 | $2.30 | -9.8% | -4.6% | -6.0% |
| Q3 FY2026 | $1.98 | $2.43 | -18.6% | -6.1% | -7.7% |
| Q2 FY2026 | $2.29 | $2.50 | -8.3% | -1.9% | -2.2% |
| Q1 FY2025 | $2.21 | $2.44 | -9.3% | +1.7% | +2.4% |
| Q4 FY2025 | $2.06 | $2.27 | -9.3% | +1.2% | +3.7% |
| Q3 FY2025 | $2.22 | $2.48 | -10.6% | +1.5% | +3.5% |
| Q2 FY2025 | $2.09 | $2.41 | -13.2% | -2.5% | -2.3% |
| Q1 FY2024 | $2.20 | $2.54 | -13.5% | -8.0% | -9.5% |
| Q4 FY2024 | $2.29 | $2.62 | -12.5% | -6.7% | -5.8% |